Application of MultiStem® allogeneic cells for immunomodulatory therapy: clinical progress and pre-clinical challenges in prophylaxis for graft vs host disease

The last decade has seen much progress in adjunctive cell therapy for immune disorders. Both corporate and institutional Phase III studies have been run using mesenchymal stromal cells (MSC) for treatment of Graft vs Host Disease (GvHD), and product approval has been achieved for treatment of pediat...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Bart eVaes, Wouter eVan 't Hof, Robert eDeans, Jef ePinxteren
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2012-11-01
Σειρά:	Frontiers in Immunology
Θέματα:	Regenerative Medicine bioreactor MultiStem GvHD prophylaxis adherent stem cells
Διαθέσιμο Online:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2012.00345/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!